For a decade, a boy in Heidelberg carried a cancer that kept returning — through his childhood, into his adolescence, across his lungs, liver, brain, and pelvis — until medicine had nothing conventional left to offer him. In 2025, a collaboration between academic researchers and a biotechnology firm reprogrammed his own immune cells to recognize and destroy what chemotherapy and surgery could not. His complete remission, now published in the New England Journal of Medicine, is not merely a medical milestone — it is a reminder that the frontier of healing is often reached only when institutions
Personalized T-cell therapy achieves complete remission in therapy-resistant kidney tumor
One teenager with advanced metastatic kidney cancer experienced complete disease remission and has returned to normal activities including vocational training and competitive cycling.